Cysteinyl leukotrienes and leukotriene B4 mediate vasoconstriction to arginine vasopressin in rat basilar artery

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 12, 2005, Pages 1027-1033

  Trandafir, Cristina C ^a   Nishihashi, Tsuyoshi ^a   Ji, Xu ^a   Wang, Aimin ^a   Kurahashi, Kazuyoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Arginine vasopressin; Cysteinyl leukotrienes; Leukotriene B4; Rat basilar artery

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; 1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; 5 ETHYL 2 HYDROXY 4 [6 METHYL 6 (1H TETRAZOL 5 YL)HEPTYLOXY]ACETOPHENONE; ARACHIDONATE 5 LIPOXYGENASE; ARGIPRESSIN; DOCEBENONE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; PEPTIDOLEUKOTRIENE; POTASSIUM CHLORIDE; VASOCONSTRICTOR AGENT; VERLUKAST; BENZOPYRAN DERIVATIVE; CARBOXYLIC ACID; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR; PROPIONIC ACID DERIVATIVE; QUINOLINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BRAIN EDEMA; BRAIN VASOSPASM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; NONHUMAN; RAT; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARGININE VASOPRESSIN; BASILAR ARTERY; BENZOPYRANS; CARBOXYLIC ACIDS; FEMALE; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LIPOXYGENASE INHIBITORS; MUSCLE, SMOOTH, VASCULAR; PROPIONATES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEUKOTRIENE; RECEPTORS, LEUKOTRIENE B4; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33644977111     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04300.x     Document Type: Article

References (36)

1. 1b receptor ligands. Prog. Brain Res. 2002 139 : 197 210.
2. Kleindienst A Hildebrandt G Kroemer SA Franke G Gaab MR Landgraf R. Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: In vivo microdialysis study. Acta Neurol. Scand. 2004 109 : 361 8.
3. Mather HM Ang V Jenkins JS. Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 1981 44 : 216 19.
4. Tsuji T Cook DA. Vasoconstrictor mechanism of neuropeptides augmented after endothelial removal in isolated, perfused canine basilar arteries. Neurol. Res. 1995 17 : 193 200.
5. García-Villalón AL García JL Fernández N Monge L Gomez B Diéguez G. Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide. Br. J. Pharmacol. 1996 118 : 1848 54.
6. Katori E Ohta T Nakazato Y Ito S. Vasopressin-induced contraction in the rat basilar artery in vitro. Eur. J. Pharmacol. 2001 416 : 113 21.
7. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 2000 11 : 406 10.
8. Nishihashi T Trandafir CC Wang A Ji X Kurahashi K. Enhanced reactivity to vasopressin in rat basilar arteries during vasospasm after subarachnoid hemorrhage. Eur. J. Pharmacol. 2005 513 : 93 100.
9. Trandafir CC Nishihashi T Wang A Murakami S Ji X Kurahashi K. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid hemorrhage. Clin. Exp. Pharmacol. Physiol. 2004 31 : 261 6.
10. de Vries HE Hoogendoorn KH van Dijk J et al. Eicosanoid production by rat cerebral endothelial cells: Stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J. Neuroimmunol. 1995 59 : 1 8.
11. Kahler J Conforto A Dudek R Termin A Bing RJ. Synthesis of leukotrienes by freshly harvested endothelial cells. J. Mol. Cell. Cardiol. 1993 25 : 647 53.
12. 4. J. Vasc. Surg. 1990 12 : 298 304.
13. Piomelli D Feinmark SJ Cannon PJ. Leukotriene biosynthesis by canine and human coronary arteries. J. Pharmacol. Exp. Ther. 1987 241 : 763 70.
14. Allen S Dashwood M Morrison K Yacoub M. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. Circulation 1998 97 : 2406 13.
15. Bigby TD. The yin and the yang of 5-lipoxygenase pathway activation. Mol. Pharmacol. 2002 62 : 200 2.
16. 1 receptor via intracellular calcium mobilization in smooth muscle cells. Br. J. Pharmacol. 2003 138 : 707 15.
17. Shastri S McNeill JR Wilson TW Poduri R Kaul C Gopalakrishnan V. Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR. Am. J. Physiol. Heart Circ. Physiol. 2001 281 : 342 9.
18. Stanke-Labesque F Devillier P Veitl S Caron F Cracowski JL Bessard G. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats. Cardiovasc. Res. 2001 49 : 152 60.
19. 4: Metabolism and signal transduction. Arch. Biochem. Biophys. 2001 385 : 231 41.
20. Mehrabian M Allayee H Wong J et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 2002 91 : 120 6.
21. Spanbroek R Grabner R Lotzer K et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl Acad. Sci. USA 2003 100 : 1238 43.
22. Helgadottir A Manolescu A Thorleifsson G et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 2004 36 : 233 9.
23. Lotzer K Spanbroek R Hildner M et al. Differential leukotriene receptor expression and calcium response in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 32 6.
24. 1 receptor. Nature 1999 399 : 789 93.
25. 4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor. Am. J. Physiol. Heart Circ. Physiol. 2004 287 : 419 24.
26. Yang Y Huang W Lu X. Early changes of endothelin, nitric oxide and arginine-vasopressin in patients with acute cerebral injury. Chin. J. Traumatol. 2002 5 : 259 62.
27. Espiner EA Leikis R Ferch RD et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin. Endocrinol. 2002 56 : 629 35.
28. 2 synthesis in fibroblasts. Eur. J. Pharmacol. 2004 485 : 53 9.
29. 4 hydrolase in guinea pig tissues. J. Biol. Chem. 1990 265 : 7520 5.
30. 4 production in ischemic brain. Am. J. Physiol. 1995 268 : 1249 57.
31. Shimizu T Watanabe T Asano T Seyama Y Takakura K. Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoid hemorrhage. J. Neurochem. 1988 51 : 1126 31.
32. 4 receptors. Prostaglandins Leukot. Essent. Fatty Acids 2003 69 : 123 34.
33. Brink C Dahlen SE Drazen J et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 2003 55 : 195 227.
34. Hwang SW Cho H Kwak J et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc. Natl Acad. Sci. USA 2000 97 : 6155 60.
35. 1) receptors. Biochem. Pharmacol. 2001 62 : 1193 200.
36. 1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 2002 33 : 3033 7.